United States Genetic Testing Market Outlook to 2024

  • ID: 4429107
  • Report
  • Region: United States
  • 449 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Luminex Corp
  • Myriad Genetics Inc
  • PerkinElmer Inc
  • MORE
United States Genetic Testing Market Outlook to 2024

Summary

The new report, United States Genetic Testing Market Outlook to 2024, provides key market data on the United States Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Luminex Corp
  • Myriad Genetics Inc
  • PerkinElmer Inc
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Genetic Testing Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Genetic Testing Market, United States
3.1 Genetic Testing Market, United States, Revenue ($m), 2010-2017
3.2 Genetic Testing Market, United States, Revenue ($m), 2017-2024
3.3 Genetic Testing Market, United States, Distribution Share by Revenue ($m), 2017
3.4 Genetic Testing Market, United States, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in United States, Genetic Testing Market
4.1 F. Hoffmann-La Roche Ltd
4.2 Abbott Laboratories
4.3 Luminex Corp
4.4 PerkinElmer Inc
4.5 Myriad Genetics Inc
4.6 Hologic Inc
4.7 Qiagen NV

5 Genetic Testing Market Pipeline Products

6 Financial Deals Landscape
6.1 Acquisition
6.2 Debt Offerings
6.3 Equity Offerings
6.4 Merger
6.5 Partnerships
6.6 Venture Financing

7 Recent Developments
7.1 Corporate Communications
7.2 Financial Announcements
7.3 Government and Public Interest
7.4 Legal And Regulatory
7.5 Other Significant Developments
7.6 Product News
7.7 Strategy And Business Planning

8 Appendix
8.1 Research Methodology
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 2: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 3: Genetic Testing Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 4: Genetic Testing Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 5: Genetic Testing Market Pipeline Products
Table 6: Invitae to Acquire Good Start Genetics
Table 7: Invitae to Acquire CombiMatrix for USD33 Million
Table 8: NantOmics Acquires Genos Research
Table 9: Omicia Acquires Spiral Genetics
Table 10: Takeda Pharma Acquires Ariad Pharma for up to USD5.2 Billion in Tender Offer
Table 11: Takara Bio Acquires Rubicon Genomics for USD75 Million
Table 12: DNA Diagnostics Center Acquires Identigene from Sorenson Genomics
Table 13: Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025
Table 14: LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024
Table 15: LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027
Table 16: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047
Table 17: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027
Table 18: Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019
Table 19: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026
Table 20: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029
Table 21: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037
Table 22: Interleukin Genetics Raises USD1 million in Issue of Subordinated Convertible Promissory Notes
Table 23: Transgenomic Raises USD1.2 Million in Private Placement
Table 24: Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million
Table 25: CareDx Raises USD20 Million in Public Offering of Shares
Table 26: NanoString Technologies Plans to Raise USD100 Million in Public Offering of Shares
Table 27: Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares
Table 28: CareDx Files Registration Statement to Raise Funds through Public Offering of Shares
Table 29: Biocept Plans to Raise Funds through Private Placement of Shares
Table 30: Invitae to Raise Funds through Public Offering of Shares
Table 31: Invitae to Raise Funds through Public Offering of Shares
Table 32: Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion
Table 33: Fluidigm Raises USD30 Million in Public Offering of Shares
Table 34: Trovagene to Raise USD7 Million in Private Placement of Shares and Warrants
Table 35: Interpace Diagnostics Raises USD13.7 Million in Public Offering of Share and Warrants
Table 36: NanoString Technologies Raises USD57.8 Million in Public Offering of Shares
Table 37: CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants
Table 38: HTG Molecular Diagnostics to Raise up to USD20 Million in Public Offering of Shares
Table 39: Miragen Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares
Table 40: Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million
Table 41: Interpace Diagnostics Raises USD3.9 Million in Public Offering of Shares
Table 42: Invitae Prices Public Offering of Shares for USD44 Million
Table 43: Protea Biosciences Group Raises USD0.6 Million in Private Placement
Table 44: Signal Genetics Merges with miRagen Therapeutics
Table 45: NuGEN Technologies Enters into Agreement with Cambridge Epigenetix
Table 46: Taconic Biosciences Enters into Agreement with Cergentis
Table 47: Agena Bioscience Enters into Co-Marketing Agreement with HeartGenetics
Table 48: Novogene Enters into Agreement with Pacific Biosciences
Table 49: AstraZeneca Enters into Partnership with DNAnexus
Table 50: Rady Children’s Hospital and Alexion Pharma Enter into Agreement
Table 51: University of Rochester School of Medicine and Dentistry and Admera Health Enter into Partnership
Table 52: Hamilton Robotics Partners with Illumina
Table 53: Lucigen Enters into Distribution Agreement with Illumina
Table 54: Fabric Genomics and TOMA Biosciences Enter into Partnership
Table 55: Kailos Genetics Enters into Co-Marketing Agreement with Illumina
Table 56: ThermaGenix Enters Licensing Agreement with Brandeis University
Table 57: OncoSec Medical Enters into Agreement with Inhibrx
Table 58: Analytik Jena Enters into Co-Development Agreement with Illumina
Table 59: Asuragen Enters into Agreement with Thermo Fisher Scientific
Table 60: RPRD Diagnostics Enters into Partnership with Children's Minnesota
Table 61: Bio-Reference Labs Terminates its Distribution Agreement with Natera for NIPD Test
Table 62: Invitae Enters into Clinical Research Agreement with TME Research
Table 63: Regeneron Genetics Center Enters into Research Agreement with Children's National Health System
Table 64: OpGen Enters into Research Agreement with Merck
Table 65: NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute
Table 66: 23andMe Raises USD250 Million in Venture Financing
Table 67: WuXi NextCODE Raises Additional USD165 Million in Series B Financing
Table 68: InVitae Raises USD16 Million in Venture Financing
Table 69: Kailos Genetics Raises Funds through Venture Financing
Table 70: Genome Profiling Raises USD0.9 Million in Venture Financing
Table 71: Personalis Raises USD12.2 Million in Venture Financing
Table 72: iNanoBio to Raise USD4 Million in Venture Financing
Table 73: WuXi NextCODE Raises USD75 Million in Series B Financing
Table 74: AltheaDx Raises USD27 Million in Series D Financing
Table 75: Geneticure Raises USD0.2 Million in Venture Financing
Table 76: Muse Biotechnology Raises USD23 Million in Series B Venture Financing
Table 77: Exonics Therapeutics Raises USD5 Million in Seed Financing
Table 78: Genomind Raises USD11 Million in Venture Financing
Table 79: Bio-Nems Raises USD0.2 Million in Venture Financing
Table 80: Kailos Genetics to Raise USD2 Million in Venture Financing
Table 81: Genos Research Raises USD6 Million in Seed Financing
Table 82: Inform Genomics to Raise USD1.4 Million in Venture Financing
Table 83: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figures
Figure 1: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 2: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 3: Genetic Testing Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Luminex Corp
  • PerkinElmer Inc
  • Myriad Genetics Inc
  • Hologic Inc
  • Qiagen NV
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll